|Last Price||Today's Change||52-Week Range||Trading Volume|
|30.15||0.05 (+0.17%)||27.76 - 32.96||12.7 million (Above Avg)|
Market data as of 11:30AM 07/29/14. Quotes are delayed by at least 15 min.
PFIZER REPORTS SECOND-QUARTER 2014 RESULTS
07/29/2014 7:00 AM ET
Bristol-Myers Squibb and Pfizer Announce Enrollment of First Patient in Phase IV EMANATE Trial to Assess Effectiveness and Safety of Eliquis® (apixaban) in Patients with NVAF Undergoing Cardioversion
07/17/2014 8:06 AM ET